Surgery for advanced bladder cancer includes transurethral resection of the bladder tumor (TURBT) to remove tumors and cystectomy to remove all or part of the bladder, with the choice depending on the ...
Two pre-TURBT 40-mg intravesical mitomycin-C instillations significantly improved long-term recurrence outcomes versus TURBT ...
Transurethral Resection of Bladder Tumor, or TURBT, is a procedure that allows your surgeon to biopsy or remove a tumor from the inside of your bladder while leaving the bladder intact. Because the ...
Long-term outcomes of pembrolizumab (pembro) in combination with gemcitabine (gem) and concurrent hypofractionated radiation therapy (RT) as bladder sparing treatment for muscle-invasive urothelial ...
Roswell Park urology experts shared studies at AUA 2026 on bladder and prostate cancer risk, pelvic floor neural mapping and ...
UGN-102 had similar disease-free survival outcomes in non-muscle-invasive bladder cancer, regardless of whether the therapy was given with surgery. Groups of patients with newly diagnosed and ...
Urothelial carcinoma is the most common bladder cancer, with stage 1 indicating early-stage disease confined to the bladder lining. Diagnosis involves urinalysis, cystoscopy, TURBT, and imaging to ...
More than 250,000 people undergo a transurethral procedure each year in the U.S., and up to 10% of those people will experience a postoperative infection. But researchers have discovered an indicator ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results